![]() BioNTech BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases. | ![]() Handa Pharmaceuticals Handa Pharmaceuticals is a company that develops and commercializes prescription medications. | ||||
Founding Date | Founding Date 1993 | Founding Date 2008 | Founding Date 2005 | Founding Date 2014 | Founding Date 2011 |
Type | Type Public | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Shenyang, CN HQ | Locations Mainz, DE HQ Halle (Saale), DE Idar Oberstein, DE Marburg, DE Neuried, DE Planegg, DE Cambridge, US see more | Locations San Jose, US HQ | Locations HQ | Locations Oslo, NO HQ Uppsala, SE |
Employees | Employees 5,3112% increase | Employees 5,500 | Employees 6 | Employees 6 | Employees 19 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 23.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 197.3 m |
Employee Rating | Employee Rating 3 | Employee Rating 3.3 | Employee Rating N/A | Employee Rating N/A | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥6.9b (FY, 2022) | Revenue (est.) €17.3b (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥821.4m (FY, 2022) | Cost of goods €2.9b (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥6.1b (FY, 2022) | Gross profit €14.5b (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ¥1.9b (FY, 2022) | Net income €9.4b (FY, 2022) | Net income N/A | Net income N/A | Net income (kr167.8m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 15.2m | Total funding raised $ 1.4b | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
BioNTech is biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
View companyHanda Pharmaceuticals is a company that develops and commercializes prescription medications.
View companyOrsenix is a clinical-stage biotech company focusing on oral therapies to treat cancer.
View companyUltimovacs is a pharmaceutical company developing immunotherapies against cancer.
View company